A carregar...
Pharmacokinetics and Pharmacodynamics of Omarigliptin, a Once‐Weekly Dipeptidyl Peptidase‐4 (DPP‐4) Inhibitor, After Single and Multiple Doses in Healthy Subjects
The pharmacokinetics (PK) and pharmacodynamics (PD) of omarigliptin, a novel once‐weekly DPP‐4 inhibitor, were assessed following single and multiple doses in healthy subjects. Absorption was rapid, and food did not influence single‐dose PK. Accumulation was minimal, and steady state was reached aft...
Na minha lista:
Publicado no: | J Clin Pharmacol |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
John Wiley and Sons Inc.
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5111764/ https://ncbi.nlm.nih.gov/pubmed/27225334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.773 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|